Screener
Arcutis Biotherapeutics, Inc. ARQT Net debt
Discontinued — last reported Q2 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Arcutis Biotherapeutics, Inc.’s reported figures.
The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001787306-26-000051
FAQ
- What is Arcutis Biotherapeutics, Inc.'s net debt?
- Arcutis Biotherapeutics, Inc. (ARQT) reported net debt of $79.71M in Q2 2026.
- How has Arcutis Biotherapeutics, Inc.'s net debt changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s net debt increased by 114.8% year-over-year, from $37.12M to $79.71M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s net debt?
- Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s net debt has grown at a 2.9% compound annual growth rate (CAGR), from -$61.66M to $71.3M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Arcutis Biotherapeutics, Inc.'s net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude